X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
oncology (10) 10
cancer (9) 9
female (9) 9
humans (9) 9
middle aged (9) 9
adult (8) 8
breast cancer (8) 8
breast neoplasms - drug therapy (8) 8
chemotherapy (8) 8
aged (7) 7
breast neoplasms - pathology (7) 7
treatment outcome (6) 6
adjuvant treatment (5) 5
breast neoplasms - surgery (5) 5
medicine & public health (5) 5
neoplasm staging (5) 5
prognosis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
chemotherapy, adjuvant (4) 4
clinical trials (4) 4
hematology, oncology and palliative medicine (4) 4
neoadjuvant therapy (4) 4
pathological complete response (4) 4
surgery (4) 4
taxoids - administration & dosage (4) 4
women (4) 4
analysis (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - mortality (3) 3
care and treatment (3) 3
cyclophosphamide (3) 3
cyclophosphamide - administration & dosage (3) 3
drug administration schedule (3) 3
health aspects (3) 3
neoadjuvant therapy - methods (3) 3
product development (3) 3
prospective studies (3) 3
surgical oncology (3) 3
therapy (3) 3
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
bevacizumab (2) 2
breast neoplasms - diagnostic imaging (2) 2
cancer therapies (2) 2
clinical outcomes (2) 2
combination (2) 2
confidence intervals (2) 2
disease-free survival (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
doxorubicin - administration & dosage (2) 2
drug therapy (2) 2
efficacy (2) 2
endothelial growth factors (2) 2
geparduo (2) 2
germany (2) 2
hematology (2) 2
mastectomy, segmental (2) 2
metastasis (2) 2
open-label (2) 2
patient compliance (2) 2
plus trastuzumab (2) 2
preoperative chemotherapy (2) 2
trial (2) 2
tumors (2) 2
ultrasonography, mammary (2) 2
young adult (2) 2
1st-line treatment (1) 1
331.6 (1) 1
albumin-bound paclitaxel (1) 1
albumins - adverse effects (1) 1
albumins - therapeutic use (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
anthracyclines - therapeutic use (1) 1
anti-angiogenesis (1) 1
antibiotics, antineoplastic - administration & dosage (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols (1) 1
anti‐angiogenesis (1) 1
arbeidsmarkt (1) 1
arbeidsmarkt; algemeen (1) 1
arbeitslosengeld (1) 1
arbeitslosenunterstützung (1) 1
arbeitsmarkt (1) 1
arbeitsmarktpolitik (1) 1
arbeitsmarktpolitik / deutschland / bundesrepublik (1) 1
arbeitsoekonomie (1) 1
arbete och arbetsmarknad: tyskland (1) 1
association (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 747 - 756
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 345 - 356
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 135 - 144
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 542 - 551
Background Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with unfavorable outcome. We compared the response of... 
THERAPY | GEPARDUO | ONCOLOGY | PROGNOSIS | CARCINOMA | CHEMOTHERAPY | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Vinblastine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Mastectomy, Segmental | Adult | Female | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Ultrasonography, Mammary | Treatment Outcome | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Carcinoma, Lobular - drug therapy | Patient Compliance | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Germany | Chemotherapy | Breast cancer | Drug therapy | Comparative analysis | Health aspects | Cancer | Side effects | Toxicity | Clinical outcomes | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 552 - 562
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 11/2019, Volume 26, Issue 12, pp. 3892 - 3901
The impact of locoregional radiotherapy (RT) after neoadjuvant chemotherapy (NACT) and mastectomy in breast cancer patients is currently unclear. Several... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Breast cancer | Radiotherapy | Analysis | Adjuvant treatment | Cancer | Index Medicus
Journal Article
by Melander, A and Olsson, J and Lindberg, G and Salzman, A and Howard, T and Stang, P and Lydick, E and Emslie-Smith, A and Boyle, D I. R and Evans, J M. M and Macdonald, T M and Bain, J and Sullivan, F and Juhl, C and Pørksen, N and Sturis, J and Hollingdal, M and Pincus, S and Veldhuis, J and Dejgaard, A and Schmitz, O and Kristensen, J S and Frandsen, K B and Bayer, Th and Müller, P and Dunning, B E and Paladini, S and Gutierrez, C and Deacon, R and Valentin, M and Grunberger, G and Weston, W M and Patwardhan, R and Rappaport, E B and Sargeant, L A and Wareham, N J and Khaw, K T and Zethelius, Björn and Lithell, Hans and Hales, C Nicholas and Berne, Christian and Lakka, H.-M and Oksanen, L and Tuomainen, T.-P and Kontula, K and Salonen, J T and Dekker, J M and de Boks, P and de Vegt, F and Stehouwer, C D. A and Nijpels, G and Bouter, L M and Heine, R J and Bruno, G and Cavallo-Perin, P and Bargero, G and D’Errico, N and Borra, M and Macchia, G and Pagano, G and Newton, R W and Ruta, D A and New, J P and Wallace, C and Roxburgh, M A and Young, R J and Vaughan, N J. A and Elliott, P and Brennan, G and Devers, M and MacAlpine, R and Steinke, D and Lawson, D H and Decallonne, B and Casteels, K and Gysemans, C and Bouillon, R and Mathieu, C and Linn, Thomas and Strate, Christine and Schneider, Kerstin and Funda, D P and Jirsa Jr, M and Kozáková, H and Kaas, A and Kofronová, O and Tlaskalová-Hogenová, H and Buschard, K and Wanka, H and Hartmann, A and Kuttler, B and Rasmussen, S B and Sørensen, T S and Markholst, H and Petersen, J S and Karounos, D and Dyrberg, T and Mabley, J G and Haskó, G and Szabó, C and ... and IMDIAB Study Group and Osaka IDDM Study Group and European Group for the Study of Insulin Resistance (EGIR) and Screen-Pol Study Group and Northern Diabetic Pregnancy Survey and Brazilian Gestational Diabetes Study Group and UK Prospective Diabetes Study Group and Hungarian HbA1c Screening Study Group and Croatian Study Group for Diabetic Amyotrophy and EURODIAB IDDM Study Group and Neuropathy Study Group of the Italian Society of the Study of Diabetes and Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and HOE 901/3003 study group and German Working Group on Quality Control and Turkish Diabetes Epidemiology Group and Mauritian NCD group and D.I.O.R. study group and Lithuanian Collaborative Group for the Epidemiology of Diabetes and DARTS/MEMO Collaboration and Cerivastatin/Bezafibrate Latin America Study Group and Pramlintide Type 1 Study Group and Non-Invasive Task Force and Childhood Diabetes in Finland Study Group and German Pediat. Working Group and EURODIAB Complications Study Group and Hvidøre Study group on Childhood Diabetes and EURODIAB Prospective Complications Study (PCS) Group and WHO/IDF Patient Empowerment Workshop and AD Morris for the DARTS/MEMO Collaboration and Pramlintide Type 2 Study Group and Finnish Diabetes Prevention Study Group and Service of internal medecine - diabetologia - vascular diseases and UKPDS Group and IGT Research Group and DAIS Project Group and KANWU study group and Cerivastatin Combination Therapy Study Group and GENEDIAB Study Group and TARDIS Steering Committee and UK centres and Rosiglitazone Study Group and GEDEC study group and HIDM investigators and US Study Group of Insulin Glargine in Type 2 DM and European Insulin Aspart Study Group and The TARDIS Steering Committee and UK centres and The Turkish Diabetes Epidemiology Group and The EURODIAB Prospective Complications Study (PCS) Group and The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and The Finnish Diabetes Prevention Study Group
Diabetologia, ISSN 0012-186X, 8/1999, Volume 42, Issue S1, pp. A1 - A330
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2015, Volume 137, Issue 12, pp. 2981 - 2988
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 8/2014, Volume 21, Issue 8, pp. 2517 - 2524
Journal Article
Breast Cancer, ISSN 1340-6868, 11/2019, Volume 26, Issue 6, pp. 826 - 834
Information on deaths occurring during oncological clinical trials has never been systematically assessed. Here, we examine the incidence of death and the... 
Medicine & Public Health | Death in clinical trial | Surgery | Rate of autopsy | Oncology | Cancer Research | Surgical Oncology | Cause of death | Chemotherapy-related death | Serious adverse events
Journal Article